Literature DB >> 19652355

Expression, purification and preliminary X-ray crystallographic analysis of UDP-galactopyranose mutase from Deinococcus radiodurans.

Sarathy Karunan Partha1, Sara A Bonderoff, Karin E van Straaten, David A R Sanders.   

Abstract

UDP-galactopyranose mutase (UGM) catalyzes the interconversion of UDP-galactopyranose and UDP-galactofuranose. A UGM-substrate complex from Deinococccus radiodurans has been expressed, purified and crystallized. Crystals were obtained by the microbatch-under-oil method at room temperature. The crystals diffracted to 2.36 A resolution at the Canadian Light Source. The space group was found to be P2(1)2(1)2(1), with unit-cell parameters a = 134.0, b = 176.6, c = 221.6 A. The initial structure solution was determined by molecular replacement using UGM from Mycobacterium tuberculosis (PDB code 1v0j) as a template model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652355      PMCID: PMC2720349          DOI: 10.1107/S1744309109027754

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  11 in total

Review 1.  The bacterial cell wall as a source of antibacterial targets.

Authors:  David W Green
Journal:  Expert Opin Ther Targets       Date:  2002-02       Impact factor: 6.902

2.  Automated search-model discovery and preparation for structure solution by molecular replacement.

Authors:  Ronan M Keegan; Martyn D Winn
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-03-16

Review 3.  Galactofuranose metabolism: a potential target for antimicrobial chemotherapy.

Authors:  L L Pedersen; S J Turco
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

4.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

5.  Cell wall core galactofuran synthesis is essential for growth of mycobacteria.

Authors:  F Pan; M Jackson; Y Ma; M McNeil
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

6.  UDP-galactopyranose mutase has a novel structure and mechanism.

Authors:  D A Sanders; A G Staines; S A McMahon; M R McNeil; C Whitfield; J H Naismith
Journal:  Nat Struct Biol       Date:  2001-10

7.  A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.

Authors:  G S Besra; K H Khoo; M R McNeil; A Dell; H R Morris; P J Brennan
Journal:  Biochemistry       Date:  1995-04-04       Impact factor: 3.162

8.  Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.

Authors:  Jennifer M Chad; Karunan Partha Sarathy; Todd D Gruber; Eshwari Addala; Laura L Kiessling; David A R Sanders
Journal:  Biochemistry       Date:  2007-05-19       Impact factor: 3.162

9.  Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state.

Authors:  Konstantinos Beis; Velupillai Srikannathasan; Huanting Liu; Stephen W B Fullerton; Vicki A Bamford; David A R Sanders; Chris Whitfield; Mike R McNeil; James H Naismith
Journal:  J Mol Biol       Date:  2005-05-13       Impact factor: 5.469

10.  A simple and efficient expression and purification system using two newly constructed vectors.

Authors:  Huanting Liu; James H Naismith
Journal:  Protein Expr Purif       Date:  2008-09-20       Impact factor: 1.650

View more
  2 in total

Review 1.  Structure, mechanism, and dynamics of UDP-galactopyranose mutase.

Authors:  John J Tanner; Leonardo Boechi; J Andrew McCammon; Pablo Sobrado
Journal:  Arch Biochem Biophys       Date:  2013-10-03       Impact factor: 4.013

Review 2.  Targeting UDP-galactopyranose mutases from eukaryotic human pathogens.

Authors:  Karina Kizjakina; John J Tanner; Pablo Sobrado
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.